Medtronic Raises Fiscal 2027 Outlook
Medtronic raised its fiscal 2027 revenue and profit forecasts due to robust demand for cardiovascular devices. Quarterly sales grew significantly, driven by strong performance in its heart rhythm products.
Xurve View
Insights:
Xurve View
MEDTRONIC PLC raised its fiscal 2027 revenue growth outlook to 7.75% on Tuesday, driven by robust demand for advanced cardiovascular devices. The medical technology firm also lifted the lower end of its annual profit forecast to $5.94 per share. Strong surgical demand and new product adoption position the company for accelerated growth across major global markets.
